Score Overview
PeriodNet IncomeRevenueScoreGrowthTrendConsistencyGrowthTrendConsistency
5 Years
—
31.14%
40%
—
—
80%
—
5 Years
Score—
Net Growth31.14%
Net Trend40%
Net Income Consistency—
Rev Growth—
Rev Trend80%
Revenue Consistency—
Phathom Pharmaceuticals Inc fundamental performance
Across Phathom Pharmaceuticals Inc's full reported history, from 2019 to 2025, revenue grew from $ 0.00 to $ 175M and net income went from -$ 209M to -$ 221M. Revenue increased in 57% of the years measured; net income in 43%.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-08-12 | $ 9.17 | — |
1 Year2025-08-12 | $ 10.38 | -11.66% |
5 Years2021-08-12 | $ 32.49 | -71.78% |
All Time2019-10-25 | $ 24.60 | -62.72% |
| Period | Last Price2026-08-12 | 1 Year2025-08-12 | 5 Years2021-08-12 | All Time2019-10-25 |
|---|---|---|---|---|
| Price | $ 9.17 | $ 10.38 | $ 32.49 | $ 24.60 |
| Return | — | -11.66% | -71.78% | -62.72% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2026 | $ 239M | -$ 99M | $ 182M |
| 2025 | $ 175M | -$ 221M | $ 129M |
| 2024 | $ 55M | -$ 334M | $ 297M |
| 2023 | $ 682K | -$ 201M | $ 381M |
| 2022 | $ 0.00 | -$ 197M | $ 155M |
| 2021 | $ 0.00 | -$ 143M | $ 183M |
| 2020 | $ 0.00 | -$ 129M | $ 287M |
| IPO2019 | $ 0.00 | -$ 209M | $ 243M |
Explore beyond PHAT
You're looking at Phathom Pharmaceuticals Inc. Members apply the same fundamental framework across all 3,860 companies we cover.
- Every HDB Score — 1, 5, 10, 20 and 30 years, plus all-time
- Revenue and Net Income Consistency for every period
- Rank all 3,860 companies by any metric, not just three
- Filter by sector and currency, and page through the whole list
- Track your holdings in a portfolio
$99/year $149 founding price
Unlock Holder Dashboard30-day money-back guarantee.
